DCM
ITCI
Driehaus Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-369,617
| Closed | -$30.9M | – | 475 |
|
|
2024
Q4 | $30.9M | Buy |
369,617
+20,199
| +6% | +$1.69M | 0.25% | 125 |
|
|
2024
Q3 | $25.6M | Buy |
349,418
+133,979
| +62% | +$9.8M | 0.22% | 136 |
|
|
2024
Q2 | $14.8M | Buy |
+215,439
| New | +$14.8M | 0.14% | 183 |
|
|
2022
Q3 | – | Sell |
-514,956
| Closed | -$29.4M | – | 418 |
|
|
2022
Q2 | $29.4M | Buy |
514,956
+26,496
| +5% | +$1.51M | 0.48% | 54 |
|
|
2022
Q1 | $29.9M | Buy |
+488,460
| New | +$29.9M | 0.37% | 89 |
|
|
2021
Q3 | – | Sell |
-272,140
| Closed | -$11.1M | – | 499 |
|
|
2021
Q2 | $11.1M | Buy |
272,140
+55,185
| +25% | +$2.25M | 0.15% | 206 |
|
|
2021
Q1 | $7.36M | Buy |
216,955
+53,437
| +33% | +$1.81M | 0.11% | 239 |
|
|
2020
Q4 | $5.2M | Buy |
163,518
+63,874
| +64% | +$2.03M | 0.08% | 245 |
|
|
2020
Q3 | $2.56M | Buy |
+99,644
| New | +$2.56M | 0.05% | 249 |
|
|
2017
Q2 | – | Sell |
-17,964
| Closed | -$292K | – | 653 |
|
|
2017
Q1 | $292K | Buy |
+17,964
| New | +$292K | 0.01% | 478 |
|
|
2016
Q3 | – | Sell |
-93,536
| Closed | -$3.63M | – | 604 |
|
|
2016
Q2 | $3.63M | Buy |
93,536
+1,740
| +2% | +$67.5K | 0.13% | 169 |
|
|
2016
Q1 | $2.55M | Sell |
91,796
-11,351
| -11% | -$316K | 0.08% | 245 |
|
|
2015
Q4 | $5.55M | Buy |
103,147
+14,586
| +16% | +$785K | 0.19% | 121 |
|
|
2015
Q3 | $3.55M | Buy |
+88,561
| New | +$3.55M | 0.13% | 182 |
|